Featured
Emre Ozcan, PhD, SVP, Head of Global Digital Health, Merck KGaA Darmstadt Germany and Omri Shor, CEO and Founder, Medisafe discussed transformative opportunities in patient engagement and digital health in 2025. They explore the integration of AI in healthcare, focusing on how it can revolutionize patient experiences and streamline healthcare processes. See the highlights:
Read More
In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in innovating rare disease treatment. Below are the highlights and the full webinar: The integration of digital tools in rare disease treatment can significantly streamline diagnosis and therapy initiation, offering a more personalized approach to patient…
Read More
We’ll be talking PDURS, omni-channel scaling, behavioral data insights and our compliant comprehensive solutions for pharma brands that can launch in 90 days. See more about what we’ll be talking about and schedule time to chat here.
Read More
Boston, MA Nov. 18 – Medisafe, the premier platform for medication management and patient retention, is announcing several groundbreaking partnerships with major pharmaceutical brands in 2024, including two program launches with top US pharma brands in the past 30 days using Medisafe Maestro (see a demo). The releases underscore Medisafe’s unmatched ability to drive innovation…
Read More
By Omri Shor Medisafe Founder and CEO For too long, the pharmaceutical industry has been content with the status quo—relying on outdated, single-channel approaches to engage patients. But the world has changed, and patients demand more. At Medisafe we recognize that the future of patient engagement is no longer confined to a single app or…
Read More
BOSTON, MA / ACCESSWIRE / September 5, 2024 / Medisafe today unveiled a game-changing expansion of its omnichannel digital platform, setting a new standard for patient engagement and retention across the pharmaceutical landscape. Patients can now seamlessly interact with digital solutions through text, web, mobile apps, wearables, and tablets-no longer confined to a single app…
Read More
We’ll be talking PDURS, omni-channel scaling, behavioral data insights and our compliant comprehensive solutions for pharma brands that can launch in 90 days. See more about what we’ll be talking about and schedule time to chat here.
Read More
Want to keep current on the FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS)? Follow the LinkedIn profiles of these professionals at the forefront of integrating digital health solutions with pharmaceutical products affected by PDURS. PDURS: The Agency Perspective Martin Culjat, PhD, Eversana – Martin Culjat is the Senior Vice President and Global…
Read More
The FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS) have sparked considerable discussion among various stakeholders, including pharmaceutical companies, healthcare organizations, and digital health advocates. While praising and supporting the FDA’s work to issue clear guidance, most also had specific requests for additional clarity, especially about clinical trial requirements for digital health software…
Read More